RBC Capital: Biohaven Stock Price Fails to Reflect Pipeline Value
What led to Biohaven’s withdrawal of the application for troriluzole in spinocerebellar ataxia? How might the stricter regulatory stance of the EMA affect future approvals compared to the FDA? What…
